Schoettker, Patrick
Degott, Jean
Hofmann, Gregory
Proença, Martin
Bonnier, Guillaume
Lemkaddem, Alia
Lemay, Mathieu
Schorer, Raoul
Christen, Urvan
Knebel, Jean-François
Wuerzner, Arlene
Burnier, Michel
Wuerzner, Gregoire
Funding for this research was provided by:
Innosuisse (32688.1)
Article History
Received: 4 February 2020
Accepted: 8 October 2020
First Online: 20 October 2020
Competing interests
: Patrick Schoettker is an advisor to Biospectal. Martin Proença, Guillaume Bonnier, Alia Lemkaddem and Mathieu Lemay are with CSEM, the owner of the oBPM technology and assignee of the oBPM patent application (WO2016138965A1), of which Martin Proença and Mathieu Lemay are inventors. Jean Degott, Gregory Hofmann, Raoul Schorer, Arlene Wuerzner, Michel Burnier and Gregoire Wuerzner have no competing interest. Urvan Christen and Jean-François Knebel are working for Biospectal SA. Innosuisse—Swiss Innovation Agency, Project no. 32688.1 IP-ICT had no role in study design, data collection nor analysis, in the writing of the report nor in the decision to submit the paper for publication.